GGTI (Pharmaxon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGGTI (Pharmaxon)
Drug Alias Namegeranylgeranyl transferase I inhibitor (Pharmaxon)GGTI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein farnesyltransferase inhibitors
TargetsProtein farnesyltransferase
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaxon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaxon
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A